heart palpitations and semaglutide GLP-1 Rate Effects: What Clinicians Should Know Effect of semaglutide on arrhythmic,

The SURMOUNT-5 trial (published in the New England Journal of Medicine, 2024) changed that

August 2025: Recent studies offer additional data that taking Zepbound increases someones chances of developing NAION (nonarteritic anterior ischemic optic neuropathy), a condition that causes permanent vision loss and blindness

Table 4 summarizes the components of the original 5As framework applied to obesity care using GLP-1 treatment

Collected cells were centrifuged and resuspended in complete RPMI-1640 medium

By delaying the entry of nutrients into the small intestine, semaglutide reduces the rapid spikes in blood sugar levels after eating, helping to control hunger and reduce food consumption